Pacific Biosciences Of California | PACB - 流动负债



金融业
股票价格
USD
资产
USD 782.37M
现金及等价物
USD 56.27M
销售成本
USD 28.9M
流动资产
USD 369.52M
流动负债
USD 65.36M
债务
USD 892.24M
股息收益率
0
EBIT
USD -53.19M
EBITDA
USD -35.4M
员工
796
EPS每股收益
USD -0.17
股本和储备
USD 2.37M
销售毛利
USD 15.74M
债务利息支出
USD 1.74M
贷款资金
USD 645.38M
市值
USD 351M
净收入
USD -40.37M
营业费用
USD 97.83M
营业利润
USD -53.19M
普通股股本
USD 301.96M
税前利润
USD -40.17M
销售收入
USD 44.65M
销售和管理费用
USD 37.24M
股票
USD 51.02M
贸易债权人
USD 13.61M
应收帐款人
USD 35.45M


流动负债 更改 日
Agilent USD 2.27B 35M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Danaher USD 7.46B 653M 2026-03
General Electric Aerospace USD 40.03B 1.05B 2026-03
Illumina USD 1.57B 19M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Pacific Biosciences Of California USD 65.36M 7.48M 2026-03
Quidel USD 962.4M 3.7M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Roche Holding CHF 28B 421M 2025-12
Standard Biotools USD 42.2M 66.1M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Waters USD 1.24B 11.8M 2025-12